Ryan Cole
Fortune : 2 M $ au 31/05/2026
Fortune : 2 M $ au 31/05/2026
Ryan Cole is currently Chief Operating Officer at Kezar Life Sciences, Inc. since 2026 and Chief Operating Officer at Aurinia Pharmaceuticals, Inc. since 2026.
Formerly, Mr. Cole was Senior Auditor at Ernst & Young LLP from 2009 to 2012 and Vice President-Operations at Odonate, Inc. from 2017 to 2021.
Mr. Cole completed an undergraduate degree at Santa Clara University in 2009.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 18/05/2026 | 116 144 ( 0,09 % ) | 2 M $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| AURINIA PHARMACEUTICALS INC. | Directeur des opérations | 23/03/2026 |
| KEZAR LIFE SCIENCES, INC. | Directeur des opérations | 11/05/2026 |
| Sociétés | Poste | Fin |
|---|---|---|
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Comptroller/Controller/Auditor | 01/05/2012 |
| ODONATE, INC. | Directeur des opérations | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Commercial Services |
Santa Clara University
Santa Clara University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aurinia Pharmaceuticals, Inc.
Aurinia Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics | Health Technology |
Kezar Life Sciences, Inc.
Kezar Life Sciences, Inc. BiotechnologyHealth Technology Discovers and develops therapies targeting protein homeostasis | Health Technology |
Odonate, Inc.
Odonate, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for cancer treatment | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national